Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments – Market Insights – Europe

The European open surgery instrument market has shown recovery from the impact of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent marginal expansion through 2032. Growth over the forecast period will be driven primarily by the continued uptake of innovative, premium-priced products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in Europe from 2019 through 2032.

The number of open surgery procedures performed will contract through 2032.

Which procedure types are seeing a decline, and which ones are increasing?

How will the dynamics across the open surgery procedure types ultimately impact market growth?

What are the forces driving or hampering growth of the various open surgery procedure types in Europe?

The changing shift toward minimally invasive surgeries and robotic-assisted laparoscopy will have an impact on open surgery procedures.

Which procedures will be more or less affected by the shift to MIS and robotic-assisted laparoscopy?

Why are some procedures more affected by this trend than others?

Open surgery instrument competitors are continuing to improve devices in an effort to address existing barriers to adoption and to improve efficacy of treatment despite the general lack of product innovations in some segments of the open surgery instrument market.

What are the new products available in the market?

Which competitor is leading on the innovation front of open surgery instrument market?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…